IMA grows and relaunches right across the board

IMA closes 2012 with a preliminary strong growth, with consolidated revenues of 734.3 million euros (+9.7%), EBITDA of 101.4 million euros (+9%) and a backlog of orders worth 404.9 million euros (+7.1%)

These results are due to the very positive trend in sales of machines in the pharmaceutical and food areas. Preliminary net debt of the Group also fell to 131.5 million euros (157.5 million in 2011) in spite of dividends paid to the sum of 36.8 million euros.
Commenting on the figures Alberto Vacchi, IMA President and CEO, underlined the validity of the investments, made both in product and in strategic acquisitions in the food packaging industry niche, including the recent share in the Swiss Group Ilapak. Last in order of time (officially the beginning of March, Ed.) the acquisition by way of the Chinese subsidiary IMA Life Beijing, of Shanghai Pharmaceutical Machinery Co. Tianyan Ltd, which designs and manufactures systems for the sterile filling of pharmaceutical liquids and powders, as well as cleaning and sterilization systems.
In addition to the preliminary results, the Board of Directors approved the issuance of non-convertible bonds to a maximum principal amount of 50 million U.S. dollars, to be placed with a limited and identified number of U.S. institutional investors.